Boswellia serrata is being actively reformulated with various nanotechnologies to improve solubility, absorption, and targeted delivery, mainly for inflammation, arthritis, cancer, wound healing, and neuroprotection.
Clinical research suggests benefit in osteoarthritis pain and stiffness, and possibly inflammatory bowel and respiratory conditions.
Nano formulations such as nanoparticles and nano emulsions significantly improve solubility, plasma exposure, and sometimes tissue targeting, allowing potentially lower doses with stronger effects.
A 2025 full‑spectrum Boswellia extract with enhanced bioavailability, co‑delivered with curcumin, reduced pain and stiffness in human subjects with joint problems, suggesting that advanced formulations can produce clinically relevant symptom relief..
Boswellia serrata is a clinically supported herbal extract for joint and musculoskeletal health, and newer delivery technologies are being developed to further improve how its active boswellic acids are absorbed by the body. Recent human trials with bioavailability‑enhanced Boswellia extracts show meaningful reductions in pain, stiffness, and inflammatory markers in osteoarthritis and spondylitis, while emerging nanoemulsion and nanoemulgel systems in preclinical studies significantly increase boswellic‑acid bioavailability and provide more sustained release, making them promising candidates for future clinical use.
Boswellia serrata has been used for centuries to treat inflammatory conditions, joint disorders, and respiratory ailments
Osteoarthritis is the most common degenerative joint disease that begins asymptomatically in middle age with progressive symptoms in advancing age. Majority of people by the age 40 years may develop osteoarthritis, especially in weight bearing joints.
After a course of therapy for 2 months, symptomatic improvement was observed at various levels with promising results in the patients of first group.
https://journals.lww.com/aayu/fulltext/2011/32040/clinical_evaluation_of_boswellia_serrata.9.aspx
The native range of this species is Indian Subcontinent. It is a tree and grows primarily in the seasonally dry tropical biome.
ATHLETES
Boswellia serrata is not a forbidden product for athletes and does not appear on the World Anti-Doping Agency (WADA) Prohibited List for 2025. It is generally regarded as safe in sports nutrition, and several sports-oriented supplements explicitly state that their Boswellia-containing formulas do not include substances banned by WADA. Athletes can use Boswellia serrata supplements without concern for anti-doping violations, provided they choose reputable products that comply with WADA regulations.
To be found in these products:
